CD8A and bladder transitional cell carcinoma: Specifically, CAFs-EVs not only decrease apoptosis and enhance invasion in BLCA cells but also impair CD8+ T cell function by delivering PD-L1, thereby reducing CD8+ T cell proliferation and infiltration.